Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
New study shows patients with obesity and with a history of cardiovascular issues taking the Novo drug were 20% less likely to suffer a cardio event
Through RSS Feeds 
New study shows patients with obesity and with a history of cardiovascular issues taking the Novo drug were 20% less likely to suffer a cardio event
